Substrate-Selective Control of Insulin-Degrading Enzyme Reveals the Untapped Enzymology of Exosites

Share

Audience

This program is open to the research community.

Date & Time(s)

Location

This seminar will take place at ZRC-105 and by Zoom webinar.

Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
Room ZRC-105
New York, NY 10065

Speaker(s)

Juan Pa Maianti, PhD
Co-founder and Principal Scientist
Exo Therapeutics
Cambridge, MA